DK0849266T3 - Hidtil ukendt polymorf form af doxazosin-mesylat (form III) - Google Patents

Hidtil ukendt polymorf form af doxazosin-mesylat (form III)

Info

Publication number
DK0849266T3
DK0849266T3 DK96120603T DK96120603T DK0849266T3 DK 0849266 T3 DK0849266 T3 DK 0849266T3 DK 96120603 T DK96120603 T DK 96120603T DK 96120603 T DK96120603 T DK 96120603T DK 0849266 T3 DK0849266 T3 DK 0849266T3
Authority
DK
Denmark
Prior art keywords
doxazosin mesylate
new polymorphic
iii
form iii
polymorphic form
Prior art date
Application number
DK96120603T
Other languages
English (en)
Inventor
Ingomar Dr Dipl-Chem Grafe
Johann Peter Dr Dipl Moersdorf
Original Assignee
Heumann Pcs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8223531&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0849266(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Heumann Pcs Gmbh filed Critical Heumann Pcs Gmbh
Application granted granted Critical
Publication of DK0849266T3 publication Critical patent/DK0849266T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DK96120603T 1996-12-20 1996-12-20 Hidtil ukendt polymorf form af doxazosin-mesylat (form III) DK0849266T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96120603A EP0849266B8 (de) 1996-12-20 1996-12-20 Neue polymorphe Form von Doxazosinmesylat (Form III)

Publications (1)

Publication Number Publication Date
DK0849266T3 true DK0849266T3 (da) 2007-06-04

Family

ID=8223531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96120603T DK0849266T3 (da) 1996-12-20 1996-12-20 Hidtil ukendt polymorf form af doxazosin-mesylat (form III)

Country Status (16)

Country Link
US (1) US6140334A (da)
EP (1) EP0849266B8 (da)
JP (1) JP4657393B2 (da)
KR (1) KR100659927B1 (da)
AT (1) ATE353892T1 (da)
AU (1) AU725253B2 (da)
CA (1) CA2225022C (da)
DE (1) DE59611417D1 (da)
DK (1) DK0849266T3 (da)
ES (1) ES2282997T3 (da)
HU (1) HU228306B1 (da)
IL (1) IL122630A (da)
NZ (1) NZ329406A (da)
PT (1) PT849266E (da)
TW (1) TW442484B (da)
ZA (1) ZA9710634B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
DE19800214A1 (de) 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
ES2164520B1 (es) * 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
DE19912063A1 (de) * 1999-03-18 2000-09-21 Knoll Ag Neues Verfahren zur Herstellung von Doxazosin-Mesylat in einer als Form A bezeichneten Kristallmodifikation
DE19912573A1 (de) * 1999-03-19 2000-09-21 Knoll Ag Arzneimittel, enthaltend Doxazosin-Mesylat der Kristallmodifikaton D
KR20100098709A (ko) 2007-12-24 2010-09-08 시플라 리미티드 독사조신 메실레이트의 결정 다형(형태 ｉｖ) 및 이의 제조방법
CN109988158A (zh) * 2018-01-03 2019-07-09 合肥立方制药股份有限公司 X晶型、含有x晶型的多沙唑嗪甲磺酸盐及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2699054A (en) * 1953-10-09 1955-01-11 Lloyd H Conover Tetracycline
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
DK154082C (da) * 1977-11-05 1989-02-27 Pfizer Analogifremgangsmaade til fremstilling af 4-amino-6,7-dimethoxy-2-(piperazin-1-yl eller homopiperazin-1-yl)-quinazolinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
US4188390A (en) 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
ATE72244T1 (de) * 1986-03-21 1992-02-15 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
DK0459666T3 (da) * 1990-05-31 1994-12-05 Pfizer Lægemidler mod impotens
WO1994009783A1 (en) * 1992-11-04 1994-05-11 Sepracor, Inc. Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition
US5412095A (en) * 1993-04-29 1995-05-02 Abbott Laboratories Terazosin monohydrochloride and processes and intermediate for its production
US5504207A (en) * 1994-10-18 1996-04-02 Abbott Laboratories Process and intermediate for the preparation of terazosin hydrochloride dihydrate
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)

Also Published As

Publication number Publication date
KR100659927B1 (ko) 2007-04-11
TW442484B (en) 2001-06-23
ES2282997T3 (es) 2007-10-16
JPH10182641A (ja) 1998-07-07
AU4844997A (en) 1998-06-25
AU725253B2 (en) 2000-10-12
IL122630A (en) 2000-02-17
CA2225022C (en) 2008-10-07
IL122630A0 (en) 1998-08-16
DE59611417D1 (de) 2007-03-29
JP4657393B2 (ja) 2011-03-23
EP0849266A1 (de) 1998-06-24
ZA9710634B (en) 1998-11-11
HUP9702477A2 (hu) 1999-04-28
PT849266E (pt) 2007-03-30
ATE353892T1 (de) 2007-03-15
HUP9702477A3 (en) 1999-06-28
EP0849266B1 (de) 2007-02-14
HU228306B1 (en) 2013-03-28
EP0849266B8 (de) 2007-10-03
NZ329406A (en) 1998-10-28
KR19980064288A (ko) 1998-10-07
US6140334A (en) 2000-10-31
HU9702477D0 (en) 1998-03-02
CA2225022A1 (en) 1998-06-20

Similar Documents

Publication Publication Date Title
RS50081B (sr) N-(3-etinilfenilamino)-6,7-bis (2-metoksietoksi)-4- hinazolinamin mezilat, bezvodni i monohidrat
DE59903869D1 (de) Verwendung von nanoskaligen sterolen und sterolestern
DE69806696D1 (de) N,N',N''-Tris(2,4-Bis(1-Hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)alkylamino)-s-triazin-6-yl)-3,3'-ethylenediiminodipropylamine, ihre Isomere und überbrückte Derivate, sowie damit stabilisierte Polymerzusammensetzungen
DK0906278T3 (da) Enantiolselektiv syntese af azetidinoner baseret på 3-hydroxy-gamma-lacton
DE69733976D1 (de) Chirurgische Bohrer und Retraktor
NO20001789L (no) Boring og sementering gjennom grunne vannstrømmer
NO940208D0 (no) Fremgangsmaate for analyse av borestrengvibrasjon
CY1108348T1 (el) Υποκατεστημενα 2-(2,6-διοξοπιπεριδιν-3-υλ)-φθαλιμιδια και μεθοδος μειωσης των tnf αλφα επιπεδων
NO985293D0 (no) Nye 2,3-disubstituerte-4(3H)-kinazolinoner
SE9901462D0 (sv) Novel compound
NO20012599L (no) Fremgangsmåte for boring
DK0849266T3 (da) Hidtil ukendt polymorf form af doxazosin-mesylat (form III)
NO308226B1 (no) FremgangsmÕte og borerigg for boring etter olje eller gass
TR200100885T2 (tr) 2-Metil-tieno-benzodiazepin formülasyonu
ATE264328T1 (de) Substituierte 3-cyano-(1.7), (1.5) und (1.8)naphthyridininhibitoren von tyrosin kinasen
DE69903934D1 (de) Z-pinchquelle von weichen röntgenstrahlung unter verwendung von verdünnungsgas
IL122420A0 (en) New polymorphic form of doxazosin mesylate (form i)
DE69926827D1 (de) Thermischer Stabilisator und damit thermostabilisierte Halogenharzzusammensetzung
ATE219672T1 (de) Verwendung von (+)-alpha-(2,3-dimethoxyphenyl)- 1(2-(4-fluorophenyl)ethyl-4-piperidinmethanol zur behandlung von depressionen und bipolaren erkrankungen
NO985621D0 (no) FremgangsmÕte og system for boring under anvendelse av skum - skumsammensetning
IL122631A0 (en) New polymorphic form of doxazosin mesylate (form II)
PT963985E (pt) Derivados de di- ou triaza-espiro(4,5)decano
IS6441A (is) 4-Amínó-6,7-dímetoxý-2-(5-metansúlfonamídó-1,2,3,4-tetrahýdróísókínól-2-ýl)-5(2-pýridýl)kinazólín mesýlat og fjölgervingar
ID26573A (id) Bentuk ke-vi dari 5, 6-dikloro-2-(isopropilamino) 1-(b-l-ribofurasonil)-1h-benzimidazol
DE69735244D1 (de) Icyp (iodocyanopindolol) rezeptor von säugetieren und dessen anwendungen